NDC 76333-170 – Ezetimibe
Ezetimibe 10 mg/1 · Tablet · Oral
Product NDC76333-170
Product details
- Brand name
- Ezetimibe
- Generic name
- Ezetimibe
- Labeler
- Orient Pharma Co., Ltd.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA215693
- Marketed since
- June 30, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Dietary Cholesterol Absorption Inhibitor
Active ingredients
- Ezetimibe 10 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 76333-170-12 | 1000 TABLET in 1 BOTTLE (76333-170-12) | Nov 13, 2023 |
| 76333-170-13 | 500 TABLET in 1 BOTTLE (76333-170-13) | Nov 13, 2023 |
| 76333-170-14 | 90 TABLET in 1 BOTTLE (76333-170-14) | Nov 13, 2023 |
| 76333-170-15 | 30 TABLET in 1 BOTTLE (76333-170-15) | Jun 30, 2022 |
Other Ezetimibe products
- 50090-7690 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-7689 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-7339 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-7338 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-3422 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-3657 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-6630 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-6631 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-7099 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 50090-7236 Ezetimibe 10 mg/1 · Tablet · A-S Medication Solutions
- 16729-433 Ezetimibe 10 mg/1 · Tablet · Accord Healthcare Inc.
- 60687-373 Ezetimibe 10 mg/1 · Tablet · American Health Packaging